In this episode, Boston Scientific’s own Global Chief Medical Officer Ian Meredith sits down with Doctors Molly Szerlip and Vinod Thourani to discuss treating TAVR patients during the COVID-19 era. 
  
Chapter 1: Treating TAVR Patients Today (0:46) 
Chapter 2: Adapting TAVR Practices to Ensure Patient Safety (8:27) 
Chapter 3: Patient and Procedural Strategy (14:55) 
Chapter 4: The Heart Team in a Virtual World (22:45) 
Chapter 5: The Impact on Clinical Trial Research (26:08)

Treating TAVR Patients During The COVID - 19 Era

Dr. Hemal Gada and Dr. Vijay Iyer dive into the debate over the efficacy of cerebral embolic protection in preventing TAVR-related stroke. 

Physicians in this episode were compensated for their participation.

Examining Cerebral Embolic Protection

A new podcast by Boston Scientific where peers discuss timely topics in the structural heart field.

Structural Heart to Heart

Popular tracks